Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SESVanderHave is a leading global player in the sugar beet seed industry, specializing in every aspect of the production process from research and breeding to final seed processing. Headquartered in Tienen, Belgium, the company was formed in 2005 through the merger of SES and VanderHave and is currently a subsidiary of the French family-owned group Florimond Desprez. The company invests nearly 15% of its annual turnover into R&D, utilizing advanced biotechnology and molecular breeding to develop high-yield sugar beet varieties with robust resistance to pests and diseases. With a presence in over 50 countries, SESVanderHave provides tailored seed solutions to farmers and the sugar industry worldwide, maintaining a significant market share in all major sugar beet-growing regions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SESVanderHave.